These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9512107)

  • 81. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.
    Becker M; Graf N; Sauter R; Allanore Y; Curram J; Denton CP; Khanna D; Matucci-Cerinic M; de Oliveira Pena J; Pope JE; Distler O; ;
    Ann Rheum Dis; 2019 Sep; 78(9):1242-1248. PubMed ID: 31227488
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years.
    Bettoni L; Geri A; Airò P; Danieli E; Cavazzana I; Antonioli C; Chiesa L; Franceschini F; Grottolo A; Zambruni A; Radaeli E; Cattaneo R
    Clin Rheumatol; 2002 Jun; 21(3):244-50. PubMed ID: 12111631
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Systemic sclerosis. A rare connective tissue disease with manifestations in many organs].
    Haugeberg G; Brodin C; Johnsen V
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3619-21. PubMed ID: 8539716
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
    Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
    Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The role of radiology in the management of systemic sclerosis.
    Madani G; Katz RD; Haddock JA; Denton CP; Bell JR
    Clin Radiol; 2008 Sep; 63(9):959-67. PubMed ID: 18718225
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dystrophic calcifications and Raynaud's phenomenon in an eight-year old girl.
    Grebeldinger SP; Tomić JM; Vijatov-Djurić GV; Radojcić BS; Vucković NM; Culafić JN
    Srp Arh Celok Lek; 2014; 142(3-4):239-42. PubMed ID: 24839783
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Mimetics of systemic sclerosis].
    Jendrek ST; Kahle B; Riemekasten G
    Z Rheumatol; 2019 Feb; 78(1):14-23. PubMed ID: 30255410
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Is there evidence for vasculitis in systemic sclerosis?
    Saketkoo LA; Distler O
    Curr Rheumatol Rep; 2012 Dec; 14(6):516-25. PubMed ID: 23065452
    [TBL] [Abstract][Full Text] [Related]  

  • 91. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Systemic sclerosis - a rare but important diagnosis in primary health care].
    Andreasson K; Lillpers K; Wollheim F; Hesselstrand R
    Lakartidningen; 2019 Sep; 116():. PubMed ID: 31573670
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis.
    Bruni C; Guiducci S; Bellando-Randone S; Lepri G; Braschi F; Fiori G; Bartoli F; Peruzzi F; Blagojevic J; Matucci-Cerinic M
    Rheumatology (Oxford); 2015 Jan; 54(1):72-6. PubMed ID: 25065009
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Visceral manifestations of diffuse scleroderma].
    Suţeanu S; Moise A; Stoicescu M
    Med Interne; 1988; 26(2):125-38. PubMed ID: 3291079
    [No Abstract]   [Full Text] [Related]  

  • 95. [Nodular regenerative hyperplasia of the liver associated with a CREST syndrome with multiorgan involvement].
    García Díaz JD; Praga Terente M; Colina Ruizdelgado F; Lizasoaín Hernández M; Mesa Latorre J
    An Med Interna; 1989 Apr; 6(4):203-6. PubMed ID: 2577486
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon.
    Istok R; Czirják L; Lukác J; Stancíková M; Rovenský J
    Rheumatology (Oxford); 2001 Feb; 40(2):140-6. PubMed ID: 11257149
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Skin disease: a cardinal feature of systemic sclerosis.
    Krieg T; Takehara K
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii14-8. PubMed ID: 19487217
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1989. A 33-year-old woman with exertional dyspnea and Raynaud's phenomenon.
    N Engl J Med; 1989 May; 320(20):1333-40. PubMed ID: 2716773
    [No Abstract]   [Full Text] [Related]  

  • 99. Clinical aspects of systemic and localized scleroderma.
    van den Hoogen FH; de Jong EM
    Curr Opin Rheumatol; 1995 Nov; 7(6):546-50. PubMed ID: 8579977
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.